Zenas Biopharma Inc (NASDAQ: ZBIO) established initial surge of 7.08% at $8.92, as the Stock market unbolted on Thursday, before settling in for the price of $8.33 at the close. Taking a more long-term approach, ZBIO posted a 52-week range of $5.83-$26.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -45.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 62.98%. This publicly-traded company’s shares outstanding now amounts to $41.79 million, simultaneously with a float of $10.15 million. The organization now has a market capitalization sitting at $372.78 million. At the time of writing, stock’s 50-day Moving Average stood at $7.69.
Zenas Biopharma Inc (ZBIO) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Zenas Biopharma Inc industry. Zenas Biopharma Inc’s current insider ownership accounts for 75.71%, in contrast to 32.34% institutional ownership. According to the most recent insider trade that took place on Feb 18 ’25, this organization’s Chief Executive Officer bought 25,000 shares at the rate of 6.67, making the entire transaction reach 166,750 in total value, affecting insider ownership by 266,155. Preceding that transaction, on Feb 07 ’25, Company’s Director bought 10,000 for 7.76, making the whole transaction’s value amount to 77,600. This particular insider is now the holder of 47,000 in total.
Zenas Biopharma Inc (ZBIO) Earnings and Revenue Records
Zenas Biopharma Inc’s EPS increase for this current 12-month fiscal period is 62.98% and is forecasted to reach -4.04 in the upcoming year.
Zenas Biopharma Inc (NASDAQ: ZBIO) Trading Performance Indicators
Let’s observe the current performance indicators for Zenas Biopharma Inc (ZBIO). It’s Quick Ratio in the last reported quarter now stands at 6.21. The Stock has managed to achieve an average true range (ATR) of 0.94. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 74.56.
In the same vein, ZBIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.90, a figure that is expected to reach -1.11 in the next quarter, and analysts are predicting that it will be -4.04 at the market close of one year from today.
Technical Analysis of Zenas Biopharma Inc (ZBIO)
Now, what If we examine the latest scores posted by [Zenas Biopharma Inc, ZBIO]. During the last 5-days, its volume was lower the volume of 0.2 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 84.05% While, its Average True Range was 0.97.
Raw Stochastic average of Zenas Biopharma Inc (ZBIO) in the period of the previous 100 days is set at 40.87%, which indicates a major fall in contrast to 92.74% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 130.17% that was higher than 105.69% volatility it exhibited in the past 100-days period.
